Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 23 Dec 2025 for Biocryst Pharmaceuticals INC, €73k. Read the official filing
Filing timeline
BuySaleCharles K. Gayer
Insider track record
Disclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Charles K. Gayer: trading record in brief
Charles K. Gayer, listed as senior executive, appears in our data through filings on Biocryst Pharmaceuticals Inc shares, published by SEC (Form 4). We count 16 filings; the first trade dates from 14 December 2021 and the latest from 22 December 2025.
The open-market side counts 1 purchase for €152k alongside 1 sale for €62k. Netting one side against the other leaves €90k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 11 share grants and 3 option exercises.
The latest filing, published on 23 December 2025, reports a share grant of €73k in Biocryst Pharmaceuticals Inc. The last insider purchase was made public on 15 May 2024, 886 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Charles K. Gayer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
11,477 shares@ US$7.4110.4% of flowCommon StockSEC:0000882796-25-000041:0
14,142 shares@ US$3.225.6% of flowCommon StockSEC:0000882796-25-000041:1
10,091 shares@ US$5.046.2% of flowCommon StockSEC:0000882796-25-000041:2
50,000 shares@ US$5.5133.9% of flowCommon StockSEC:0000882796-25-000041:3
471,000 shares0Common StockSEC:0001171843-25-008038:0
8,181 shares@ US$7.577.1% of flowCommon StockSEC:0000882796-25-000036:0
2,461 shares@ US$7.392.5% of flowCommon StockSEC:0001127602-24-029971:1
125,950 shares0Common StockSEC:0001127602-24-029971:0
8,251 shares@ US$7.538.5% of flowCommon StockSEC:0001127602-24-029602:0
30,000 shares@ US$5.4721.9% of flowCommon StockSEC:0001127602-24-015363:0
Canonical exit: 11 Aug 2024 (T+90)
2,482 shares@ US$6.052.0% of flowCommon StockSEC:0001127602-23-030185:0
34,000 shares0Common StockSEC:0001127602-23-029833:0
34,000 shares0Common StockSEC:0001127602-22-028076:0
6,100 shares@ US$10.909.0% of flowCommon StockSEC:0001127602-22-027875:0
80,000 shares0Common StockSEC:0001127602-22-001454:0
125,000 shares0Common StockSEC:0001127602-21-031137:0
16 of 16 declarations
